Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
about
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.Combination of Fe/Cu -chelators and docosahexaenoic acid: an exploration for the treatment of colorectal cancer.Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
P2860
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@ast
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@en
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@nl
type
label
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@ast
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@en
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@nl
prefLabel
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@ast
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@en
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@nl
P2093
P2860
P356
P1433
P1476
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives
@en
P2093
Julian Holch
Sebastian Stintzing
Volker Heinemann
P2860
P304
P356
10.1159/000446052
P407
P577
2016-06-01T00:00:00Z